Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tüting

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Pigment Cell & Melanoma Research|December 15, 2018
Detection of a multilineage mosaic NRAS mutation c.181C>A (p.Gln61Lys) in an individual with a complex congenital nevus syndromeMaximilian Ulrich, Sigrid Tinschert, Eberhard Siebert, et al.
The Journal of Investigative Dermatology|June 16, 2005
Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosusJoerg Wenzel, Stephanie Henze, Eva Wörenkämper, et al.
Immunity|September 3, 2013
Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensingNadine Gehrke, Christina Mertens, Thomas Zillinger, et al.
Clinical & Translational Immunology|May 10, 2021
The myeloid cell type I IFN system promotes antitumor immunity over pro-tumoral inflammation in cancer T-cell therapyJanne Ruotsalainen, Dorys Lopez-Ramos, Meri Rogava, et al.
Frontiers in Immunology|January 7, 2016
Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem CellsKun-Hui Lu, Amel Tounsi, Naveen Shridhar, et al.
Cancer Gene Therapy|February 15, 2024
Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 miceMiriam Mengoni, Andreas Dominik Braun, Sahithi Seedarala, et al.
International Journal of Cancer|July 29, 2005
Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skinJulia Steitz, Stefanie Büchs, Damia Tormo, et al.
International Journal of Molecular Sciences|January 17, 2020
Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact HypersensitivityEvelyn Gaffal, Andrea M Kemter, Stefanie Scheu, et al.
Journal of the American Academy of Dermatology|February 19, 2008
CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host diseaseJoerg Wenzel, Svenja Lucas, Sabine Zahn, et al.
Plos One|December 15, 2010
Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide librariesWolfram Osen, Sabine Soltek, Mingxia Song, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Pigment Cell & Melanoma Research|December 15, 2018
Detection of a multilineage mosaic NRAS mutation c.181C>A (p.Gln61Lys) in an individual with a complex congenital nevus syndromeMaximilian Ulrich, Sigrid Tinschert, Eberhard Siebert, et al.
The Journal of Investigative Dermatology|June 16, 2005
Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosusJoerg Wenzel, Stephanie Henze, Eva Wörenkämper, et al.
Immunity|September 3, 2013
Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensingNadine Gehrke, Christina Mertens, Thomas Zillinger, et al.
Clinical & Translational Immunology|May 10, 2021
The myeloid cell type I IFN system promotes antitumor immunity over pro-tumoral inflammation in cancer T-cell therapyJanne Ruotsalainen, Dorys Lopez-Ramos, Meri Rogava, et al.
Frontiers in Immunology|January 7, 2016
Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem CellsKun-Hui Lu, Amel Tounsi, Naveen Shridhar, et al.
Cancer Gene Therapy|February 15, 2024
Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 miceMiriam Mengoni, Andreas Dominik Braun, Sahithi Seedarala, et al.
International Journal of Cancer|July 29, 2005
Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skinJulia Steitz, Stefanie Büchs, Damia Tormo, et al.
International Journal of Molecular Sciences|January 17, 2020
Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact HypersensitivityEvelyn Gaffal, Andrea M Kemter, Stefanie Scheu, et al.
Journal of the American Academy of Dermatology|February 19, 2008
CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host diseaseJoerg Wenzel, Svenja Lucas, Sabine Zahn, et al.
Plos One|December 15, 2010
Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide librariesWolfram Osen, Sabine Soltek, Mingxia Song, et al.
Pageof 16